Skip to content
OpenCapital
Get started

Harvard Bioscience HBIO Q4 2025 Annual earnings

Reported March 12, 2026 · Before market open

Revenue$23.7MBeat by $635.0KDiluted EPS-$0.01Miss by $0.36
Revenue estimate$23.1M
EPS estimate$0.35

Next report

Aug 10, 2026 (In 4 weeks)
Revenue estimate$21.5M
EPS estimate-$0.21

Versus estimates

Revenue

Q1 2026$20.8MMiss by $445.0K
Q4 2025$23.7MBeat by $635.0K
Q3 2025$20.6MMiss by $2.5MQ2 2025$20.5MBeat by $1.5MQ1 2025$21.8MBeat by $374.0KQ4 2024$24.6MBeat by $3.6M

Diluted EPS

Q1 2026-$0.33Beat by $0.29
Q4 2025-$0.01Miss by $0.36
Q3 2025-$0.01Miss by $0.02Q2 2025-$0.01Beat by $0.02Q1 2025-$0.01Beat by $0.03Q4 2024$0.06Beat by $0.01

Ask the moment Harvard Bioscience reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Harvard Bioscience report Q4 2025 earnings?
Harvard Bioscience (HBIO) reported Q4 2025 earnings on March 12, 2026 before market open.
What were Harvard Bioscience's Q4 2025 revenue and EPS?
Harvard Bioscience reported revenue of $23.7M and diluted EPS of $-0.01 for Q4 2025.
Did Harvard Bioscience beat estimates in Q4 2025?
Revenue beat the consensus estimate of $23.1M by $635.0K. EPS missed the consensus estimate of $0.35 by $0.36.
How did Harvard Bioscience's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.3% from $24.6M a year earlier.
Where can I find Harvard Bioscience's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001171843-26-001447) and the 10-K periodic report (0001171843-26-001548) directly on SEC EDGAR. The filing index links above go to sec.gov.